Medicamen Biotec

Medicamen Biotech Ltd Half Yearly Results

NSEBSE

₹363.5

(2.71%)

Oct 30, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2025	Sept-2024	Mar-2024	Sept-2023	Mar-2023
Gross Sales	74.76	87.79	93.82	85.48	74.25
Excise Duty	0	0	0	0	0
Net Sales	74.76	87.79	93.82	85.48	74.25
Other Operating Income	0	0	0	0	0
Other Income	5.37	0.88	1.4	0.93	0.98
Total Income	80.12	88.67	95.22	86.41	75.22
Total Expenditure	69.66	79.03	83.18	73.89	61.88
PBIDT	10.47	9.64	12.04	12.53	13.34
Interest	1.41	1.75	2.53	1.86	1.54
PBDT	9.06	7.89	9.51	10.66	11.8
Depreciation	2.69	4.38	3.58	3.51	3.22
Minority Interest Before NP	0	0	0	0	0
Tax	1.75	1.89	1.78	2.44	1.86
Deferred Tax	-0.17	-0.15	0.08	-0.72	-0.82
Reported Profit After Tax	4.79	1.77	4.07	5.42	7.54
Minority Interest After NP	0	-0.55	-1.17	-0.27	-0.12
Net Profit after Minority Interest	4.79	2.32	5.24	5.69	7.65
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	4.79	2.32	5.24	5.69	7.65
EPS (Unit Curr.)	3.53	1.39	4.14	4.29	6.05
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	12.71	12.71	12.71	12.65	12.65
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	14	10.98	12.83	14.65	17.96
PBDTM(%)	-	-	-	-	-
PATM(%)	6.4	2.01	4.33	6.34	10.15

No Record Found

Invest wise with Expert advice